Chardan Healthcare Acquisition Corp.
Status: Deal Closed
U=S+W
W=S/2@11.5
| IPO Proceeds, $M | $70.00M |
|---|---|
| IPO Date | Dec 14, 2018 |
| CEO | Jonas Grossman |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | BioMx |
| Deal Announced | Jul 16, 2019 |
| Deal Size, $M | $253.75M |
| Deal Sector | Healthcare |
| Deal Geography | EEMEA |
| SEC Filings | www.sec.gov |
| Approval Vote | Oct 23, 2019 |
| Amendment Vote | TBD |
| Closing Date | Oct 28, 2019 |
Formerly CHAC
PHGE
PHGE.W
| Price | $0.66 $0.07 |
|---|---|
| Last closing price | $0.65 |
| H/L, today | $0.65 / $0.67 |
| H/L, 52-week | $0.13 / $0.69 |
| Volume, today | 2,548 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Chardan Healthcare Acquisition Corp.:
- Structure and cap table
- 8 directors & officers
- 25 filings and events
- 3 underwriters
- 2 deal advisors
- 5 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Gbola Amusa | 44 | Executive Chairman of the Board |
| Jonas Grossman | 44 | President, CEO & Director |
| George Kaufman | 42 | CFO, Head of Strategy & Director |
| Michael Rice | 53 | Director |
| Richard Giroux | 46 | Director |
| Matthew Rossen | 41 | Director |
| Dr. Eric Kusseluk | 43 | Director |
| Sukumar Nagendran, MD | Special Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 6,965,000 | units |
| Brookline Capital Markets | 35,000 | ||
| B. Riley FBR | 1 | ||
| 7,000,001 | units | ||
| Up-Front UW fee | 0.71 | % | |
| Deferred UW fee |
0.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.